Tag Archives: Advisor

OnabotulinumtoxinA Therapy May Reduce Frequency, Severity of New Daily Persistent Headache – Clinical Pain Advisor

January 15, 2019 Share this content: OnabotulinumtoxinA injections were typically administered at the clinic every 3 months. OnabotulinumtoxinA therapy may effectively reduce the frequency and severity of new daily persistent headache at 12 months, according to a small study published in Clinical Neuropharmacology. The investigators of this single-center, retrospective study sought to examine the effectiveness of… Read More »

Neuroimaging in Headache Disorders: When Is It Necessary? – Neurology Advisor

November 30, 2018 Share this content: The use of neuroimaging remains at the discretion of the clinician, necessitating more research to improve clinical understanding of headache disorders. The World Health Organization defines headache disorders as any illness characterized by frequent headaches, the most common being migraines, tension-type headaches, cluster headaches, and medication overuse headaches.1 In… Read More »